CoChat

The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study

Wang, Xiaoliang, Fan, Yimin, Li, Guanjun, Li, Huafang · 2021 · International Clinical Psychopharmacology

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Abstract

The aim of the study was to conduct a multicenter randomized double-blinded placebo-controlled clinical study to evaluate the efficacy of a generic form of escitalopram in treating major depressive disorder (MDD). A total of 390 MDD patients admitted to hospitals in six cities in China were randomized to receive the generic version of escitalopram, the proprietary form of escitalopram (Lexapro) or placebo. During the 8-week treatment, the Hamilton rating scale for depression-17 (HAM-D 17), Hamilton Anxiety Rating Scale (HAMA), Montgomery-Åsberg Depression Rating Scale (MADRS), Clinical Global Impressions scale (CGI), current visual analogue scale pain levels (VAS-P1) and Sheehan Disability Scale (SDS) assessments were performed at week 0, 1, 2, 4, 6 and 8 to evaluate treatment responses. HAM-D 17, MADRS, HAMA and CGI-S levels of patients who received escitalopram or Lexapro decreased steadily during 8 weeks’ treatment, whereas the placebo group showed a relatively smaller reduction of these levels (P < 0.001). SDS and VAS-P1 both decreased after treatment with generic escitalopram or proprietary escitalopram Lexapro. Our results indicated that both the generic escitalopram and proprietary escitalopram Lexapro had potent efficacy in treating MDD.

Overview

Integrity signals

Registry

Crossref · 10.1097/yic.0000000000000350

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 20 references

Cited by

See all 4

Metadata

Authors
Wang, X., Fan, Y., Li, G., & Li, H.
Affiliations
Shanghai Jiao Tong University (CN)
Corresponding author
  • Li, Guanjun
  • Li, Huafang
Venue
International Clinical Psychopharmacology
Published
2021-05
Volume
36
Issue
3
Pages
133-139
ISSN
0268-1315 (ISSN-L)
OpenAlex
W3145695501
Cited by
4
References
20
Citations by year
2024: 2 · 2023: 2
FWCI
0.58
Type
journal article
Language
en
Open access
closed
Locations
  • International Clinical Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
Keywords
escitalopram, major depressive disorder, generic drugs, antidepressant efficacy, selective serotonin reuptake inhibitors, anxiety symptoms, disability, pain, hospital outpatients
MeSH terms
Escitalopram, China, Major Depressive Disorder, Double-Blind Method, Humans, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study. https://app.cochat.ai/papers/10.1097/yic.0000000000000350
The paper
Wang, X., Fan, Y., Li, G., & Li, H. (2021). The efficacy of escitalopram in major depressive disorder: a multicenter randomized, placebo-controlled double-blind study. International Clinical Psychopharmacology. https://doi.org/10.1097/yic.0000000000000350

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.